Position
Squarepoint Ops LLC in Lexeo Therapeutics, Inc.
Back to the book · All holders of LXEO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$388K$9.93 → $5.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 92.6K | $919.6K | — | — | — | 0.0% |
| Q1 2026 | 319.1K | $1.83M | $5.74 | −$388K | $1.3M | 0.0% |